You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Genetically engineered organisms (GEOs) have been under development for more than 20 years while GE crops have been grown commercially during the last decade. During this time, a number of questions have cropped up concerning the potential consequences that certain GEOs might have on natural or managed ecosystems and human health. Interest in developing methods to confine some GEOs and their transgenes to specifically designated release settings has increased and the success of these efforts could facilitate the continued growth and development of this technology. Biological Confinement of Genetically Engineered Organisms examines biological methods that may be used with genetically engineer...
Potential benefits from the use of genetically modified organismsâ€"such as bacteria that biodegrade environmental pollutantsâ€"are enormous. To minimize the risks of releasing such organisms into the environment, regulators are working to develop rational safeguards. This volume provides a comprehensive examination of the issues surrounding testing these organisms in the laboratory or the field and a practical framework for making decisions about organism release. Beginning with a discussion of classical versus molecular techniques for genetic alteration, the volume is divided into major sections for plants and microorganisms and covers the characteristics of altered organisms, past experience with releases, and such specific issues as whether plant introductions could promote weediness. The executive summary presents major conclusions and outlines the recommended decision-making framework.
Written in a practical, didactic format designed to deliver point-of-care information to practitioners of cardiology as well as assist non-cardiologists with the efficient management of cardiac disease, this highly illustrated manual is an essential reference.
Gene Containment provides a comprehensive look at genetically modified organisms and the strategies and implementation of key methods to gene containment. The book is divided into 5 parts: An Introduction that discusses the need for biotechnology and GMOs, Section 1 looks at the need for gene containment, Part II discusses varying strategies for gene containment, section III explores the assessment of gene containment approaches, and section IV covers the steps involved in implementing gene containment. Gene Containment will provide a thorough and up to date look at gene containment research and the needs for implementing new strategies in this arena.
Brazil has emerged as a significant financial and industrial power in recent times. Brazil is poised to become a significant player in the field of biotechnology, internationally, by taking advantage of circumstances not available in other countries, particularly its native biodiversity. This will, in turn, have an effect on commercial and entrepreneurial opportunities in the region. Topics covered in this text include adjustments that must be made in the regulatory framework to assure the success of business investment. This investment is crucial for training R&D scientists and developing new technologies. The book also covers a debate on transgenic plants which had political ramifications in the region and slowed the adoption rate of genetically modified organisms by almost a decade. The opportunities for commercialization of recombinant DNA technologies in the country are also presented. Opportunities and Limitations For Biotechnology Innovation In Brazil presents a concise overview of the biotechnology industry in Brazil and will be of great interest to a wide range of readers including researchers, biotechnology graduates, as well as both local and international investors.
The dynamics of transatlantic relations in the twenty-first century have been shaped by an American preference for the exercise of its considerable 'hard power' capabilities while Europeans have preferred to draw upon the considerable 'soft power' resources that have grown from their enviable internal processes of integration. These diverging power preferences have differential impacts on the management of Atlantic security, economic, and social and cultural relations. The contributors, long-time observers and analysts of the Atlantic partnership, debate how problematic security relations are likely to continue to be, discuss how successfully economic affairs will be managed, and examine the continuing frictions in domestic politics of social and cultural matters that should be manageable if both European and American leaders work actively and responsibly to encourage policy convergence.
Sustaining the new bioeconomy requires a global biotechnology governance regime to bring a large number of developing countries into the global trading system. Failure to do so will create a "genetic divide" among countries and is likely to intensify public opposition to biotechnology. This interdisciplinary collection of perspectives from the developing world - on debates over the relationships between biotechnology, biosafety, sustainable development and trade - seeks to bridge the gap between the different areas of regulatory activities and academic research and between the various stakeholders in the debate. Leading experts, writing for the International Centre for Trade and Sustainable Development, examine: the risks and opportunities of biotechnology; biosafety; intellectual property rights and related issues of access to genetic resources; benefit-sharing and traditional knowledge; biotechnological development; capacity building; the Cartagena Protocol on Biosafety; relevant WTO provisions; and developing countries' options in the WTO context.